Mahaflox-LP Eye Drop is a combination ophthalmic solution containing Loteprednol etabonate 0.5% w/v, a corticosteroid with potent anti-inflammatory properties, and Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic. This formulation is indicated for the treatment of ocular inflammatory conditions accompanied by bacterial infections or at risk of secondary bacterial infection. Loteprednol etabonate acts by inhibiting the release of inflammatory mediators, thereby reducing inflammation, edema, and pain, while Moxifloxacin exerts bactericidal activity by inhibiting bacterial DNA gyrase and topoisomerase IV, effectively targeting a wide range of gram-positive and gram-negative pathogens. Mahaflox-LP Eye Drop is commonly prescribed for postoperative inflammation following ocular surgery, bacterial conjunctivitis, keratitis, and other inflammatory ocular conditions where bacterial infection is suspected or confirmed. The combination therapy offers the dual benefit of controlling inflammation and eradicating bacterial pathogens, minimizing the need for multiple medications and improving patient compliance. It is important to use this medication under strict ophthalmologic supervision, as prolonged use of corticosteroids may increase the risk of elevated intraocular pressure, cataract formation, or secondary infections. Patients should adhere to prescribed dosing schedules and report any adverse reactions promptly.